One-year outcomes of novel VEGF decoy receptor therapy with intravitreal conbercept in diabetic retinopathy-induced macular edema

PURPOSE: Conbercept is a novel recombinant fusion protein designed as a decoy receptor for vascular endothelial growth factor (VEGF) and placental growth factor. The primary purpose was to investigate the effect and safety of conbercept, based on a practical protocol, in the eyes of patients with di...

詳細記述

保存先:
書誌詳細
出版年:Mol Vis
主要な著者: Zhou, Qingyun, Guo, Chao, You, Ailing, Wang, Desai, Wang, Wenyan, Zhang, Xuedong
フォーマット: Artigo
言語:Inglês
出版事項: Molecular Vision 2019
主題:
Research Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6817735/
https://ncbi.nlm.nih.gov/pubmed/31700228
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料